An open labelled single centric prospective clinical trial for evaluating the therapeutic efficacy of a Siddha regimen in the management of Athithoolam Atitula noy obesity Class I and II

This open-labelled, single-centric, prospective clinical trial aims  to evaluate the therapeutic efficacy of a Siddha regimen (Karunjeeraga Chooranam, Kukil parpam tablet, Naththaichoori chooranam) at Ayothidoss Pandithar Hospital Chennai, in managing Class 1 and 2 obesity. Participants aged between 18 and 60 years with a BMI greater than or equal to 30 kg/m², who meet the specified inclusion and exclusion criteria, will be enrolled in the trial. They will receive the trial regimen for an initial period of 48 days, followed by a 7-day drug-free interval, and then continue the regimen for an additional 48 days. The primary objective is to achieve a 5-10% reduction in BMI and anthropometric measurements, while secondary objectives include assessing changes in laboratory parameters and quality of life. The study excludes vulnerable groups, hypothyroidism, and malignancy, aiming to provide evidence on the efficacy of Siddha medicine in obesity management.